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PHARMACY 421 -  MEDICINAL CHEMISTRY  I  AUTUMN SEMESTER, 2001 
 
INSTRUCTORS: 
  David Freeman, Office: SB 308          Office Phone: 243-4772        Home Phone: 728-6551 
  E-mail: dfreeman@selway.umt.edu  
Internet Site: http://skaggs-06.pharmacy.umt.edu/pharm-sci/Freeman/PHAR%20421/  
  Chuck Thompson, Office: SB 383  Office Phone: 243-4643 
  E-mail:  cmthomp@selway.umt.edu 
  Internet Site: http://www.umt.edu/medchem/teaching/part1syl.htm 
 
EXAMS AND GRADING: 
  First Exam:  Friday, Oct. 5  . . . . . . . . . .   50 points 
  Second Exam:  Friday, Nov. 2  . . . . . . . . . .   70 points 
  Third Exam:  Friday, Dec. 7 . . . . . . . . . .    80 points 
  Final Exam:  Wednesday, Dec. 19 . . . . .  100 points  
  10 Point Quizzes: Best 5 out of 6 scores . . . . . .   50 points 
  Total Points:  350        90-100% = A        80-89 % = B        70-79 % = C        65-69 % = D 
    * All EXAMS are comprehensive 
    * All exams and quizzes must be taken at scheduled times 
    * Instructor must be informed BEFORE missing a scheduled exam period  
     and must be based on GOOD REASONS  
    * Missed exam periods must be made up within 2 days 
    * No make up quizzes 
 
STUDENT PERFORMANCE OBJECTIVES: 
1) Identify organic functional groups and know their polar/lipophilic and acid/base properties  
2) Know the relationships between organic functional groups and biological activity 
3) Know the possible modes of metabolism in the body for organic functional groups 
4) Know the chemical structures of important neurotransmitters or hormones and the biochemical 
    pathways for their syntheses and metabolism  
 5) Know the major biochemical events triggered by the activation of receptors important for drug action  
 6) Given the chemical structure of a drug, know its pharmacologic or therapeutic class  
 7) Given the chemical structure of a drug, know important chemical features (acid/base or lipophilic  
     properties, chemical groups affecting absorption, distribution, or metabolism, chemical groups 
     affecting potency or receptor interaction, chemical groups affecting storage or formulation) 
     that contribute to the drug's pharmacological activity  
 8) Given the chemical structure of a drug, know important chemical changes that will predictably 
     alter the pharmacological properties (potency, duration of action, etc.) of the drug  
 9) Given the chemical structure of a drug, know the important biological receptors it interacts 
     with and the biochemical events produced by these interactions  
 10) Given the common or generic name of a drug, know its pharmacologic or therapeutic class, 
     some of its important chemical properties (structural skeleton or chemical class, acid/base, etc.), 
     the receptors it interacts with and the biochemical events produced by these interactions  
  
TEXTBOOK:  Goodman & Gilman's "The Pharmacological Basis of Therapeutics",  Tenth Edition  
 
  I. Physicochemical Properties of Drugs Related to Pharmacological Activity and Metabolism 
A. Organic Functional Groups in Medicinal Chemistry 
 1.  Physicochemical Properties  
   2.  Metabolic Fate 
  B.  Acid/Base Review  
   1.  Equilibrium 
   2.  pKa values 
C. Quantitative Structure-Activity Relationships 
1. Concept of Linear Free Energy Relationships 
2. Hydrophobicity and Log P values 
3. Electronic Effects and Sigma values 
D.  Problem Solving in Medicinal Chemistry 
 
 II.  Biochemical Processes Affecting Drugs and Pharmacological Activity 
  A.  Processes Affecting Drug Distribution  
   1.  Non-specific binding sites and plasma protein binding 
   2.  Biotransformation reactions (metabolism) 
 
 
 
  B.  Processes Affecting Drug Action at the Active Site 
   1. Structural families of receptors 
   2.  Binding events initiating the pharmacological response 
    a.  Occupancy and conformational changes of receptor  
    b.  Agonist vs. antagonist events  
   3.  Events propagating and amplifying pharmacological response 
   4.  Events terminating the pharmacological response 
 
 III.  Processes and Overview of Drugs Affecting Cholinergic Receptors 
  A. Biochemical Events at the Cholinergic Synapse  
  1.  Synthesis and metabolism of acetylcholine  
   2.  Muscarinic and nicotinic receptors  
   3.  Processes following receptor activation  
  B.  Overview on Cholinergic Drugs 
 
 IV.  Muscarinic Receptor Agonists 
 A.  Chemistry of Acetylcholine 
   1.  Important functional groups  
   2.  Conformations of acetylcholine 
  B.  SAR and Chemistry of Selected Agonists  
   * METHACHOLINE  CARBACHOL  BETHANECHOL  PILOCARPINE  CEVIMELINE * 
 
  
 V.  Anticholinesterase Agents  
  A.  Mechanism of Acetylcholine Hydrolysis  
   1.  Individual steps involved in hydrolysis  
   2.  Rates of reaction steps  
  B.  Mechanisms of Cholinesterase Inhibition  
   1.  Competitive binding at active site  
   2.  Covalent binding at active site  
  C.  SAR and Chemistry of Cholinesterase Inhibitors  
   1.  Natural product and model agent   * PHYSOSTIGMINE *  
   2.  Competitive inhibitors  * EDROPHONIUM * 
   3.  Carbamates - "reversible" inhibitors 
    * NEOSTIGMINE   PYRIDOSTIGMINE * 
   4.  Organophosphates - "irreversible" inhibitors  
    * ECHOTHIOPHATE  ISOFLUROPHATE  PARATHION  MALATHION * 
  D.  Reactivation of Inhibited Cholinesterase    * PRALIDOXIME * 
 
 
 VI.  Cholinergic Antagonists  
 A.  Muscarinic Blocking Agents  
   1.  Natural product and model agent - atropine  
   2.  SAR and chemistry of selected antimuscarinic agents  
    a.  Tertiary amines  
     * ATROPINE  SCOPOLAMINE  HOMATROPINE    
     * DICYCLOMINE  CYCLOPENTOLATE * 
    b.  Quaternary amines  
     * GLYCOPYRROLATE  METHANTHELINE * 
     * PROPANTHELINE   IPRATROPIUM * 
 
 
 VII.  Agents Acting At Nicotinic Receptors 
  A. Properties of the Nicotinic Cholinergic Receptor 
  B.  Neuromuscular blocking agents  
   1.  Natural product and model agent   * TUBOCURARINE * 
   2.  Competitive agents   * MIVACURIUM   ATRACURIUM   PANCURONIUM *  
   3.  Depolarizing agents    * DECAMETHONIUM  SUCCINYLCHOLINE  * 
  C.  Ganglionic blocking agents  
    * HEXAMETHONIUM  TRIMETHAPHAN   MECAMYLAMINE * 
 
 
 
 VIII.  Processes and Overview of Drugs Affecting Adrenergic Receptors 
  A.  Biochemical Events at the Adrenergic Synapse  
   1.  Synthesis and storage of norepinephrine  
   2.  Termination and metabolism of catecholamines 
   3.  Alpha and beta receptors and subtypes  
   4.  Processes following receptor activation  
  B.  Overview on Adrenergic Drugs 
 
 
 IX.  Adrenergic Receptor Agonists 
  A.  Chemistry of Norepinephrine and Epinephrine  
   1.  Oxidative and acid/base properties  
   2.  Stereochemistry 
  B.  SAR and Chemistry of Selected Agonists  
   1.  Differentiating alpha and beta activity  
   2.  Decreasing metabolism  
   3.  Peripheral vs. CNS effects  
   4.  Direct and indirect effects  
    * DOPAMINE  ISOPROTERENOL  TERBUTALINE  METAPROTERENOL * 
    * ALBUTEROL  SALMETEROL  EPHEDRINE  PHENYLPROPANOLAMINE * 
    * RITODRINE   CLONIDINE   AMPHETAMINE  TETRAHYDROZOLINE * 
    * METHYLPHENIDATE   DOBUTAMINE   METHOXAMINE  PHENYLEPHRINE 
    * PHENTERMINE  FENFLURAMINE  METHYLPHENIDATE  PEMOLINE  COCAINE * 
   5.  Physiological and biochemical mechanisms 
 
 X.  Adrenergic Receptor Antagonists  
  A.  Alpha Blocking Agents  
   1.  Chemistry of haloalkylamines  * PHENOXYBENZAMINE * 
   2.  Chemistry of imidazolines  * PHENTOLAMINE   TOLAZOLINE * 
   3.  Selective blockers         * PRAZOSIN   TERAZOSIN   DOXAZOSIN *  
  B.  Beta Blocking Agents  
   1.  Nonselective blockers  
    * PROPRANOLOL  NADOLOL  TIMOLOL   PINDOLOL   CARTEOLOL *  
   2.  Selective blockers  * METOPROLOL  ATENOLOL  ACEBUTOLOL   ESMOLOL *  
   3.  Blockers with intrinsic sympathomimetic activity (ISA blockers) 
   4.  Combined alpha and beta blocker   * LABETALOL * 
 
 XI.  Antihistamines and Other Agents 
  A.  Biochemistry of Histamine Synthesis, Metabolism, and Receptors 
  B.  H1 receptor antagonists 
   * DIPHENHYDRAMINE   CHLORPHENIRAMINE  CYCLIZINE  PYRILAMINE * 
   * PROMETHAZINE  TERFENADINE  LORATADINE  ASTEMIZOLE  FEXOFENADINE * 
  C.  H2 receptor blocking agents 
   * CIMETIDINE  RANITIDINE  FAMOTIDINE  NIZATIDINE * 
  D.  Inhibitors of H+/K+ ATPase  
   * OMEPRAZOLE   LANSOPRAZOLE  RABEPRAZOLE  PANTOPRAZOLE * 
  E.  Inhibitors of histamine release 
   * CROMOLYN SODIUM    NEDOCROMIL SODIUM *  
 
 XII.  Local and General Anesthetics 
  A.  SAR and Chemistry of Local Anesthetic Agents 
   1.  Natural product and model compound    * COCAINE * 
   2.  Synthetic esters and amides    
    * PROCAINE  LIDOCAINE  TETRACAINE  ETIDOCAINE * 
    * BENZOCAINE   PRAMOXINE * 
  B.  Nonspecific and Specific Effects on Neural Membranes 
  C.  Factors Affecting Activity of Agents 
  D.  Adverse effects and metabolism  
   E.  Structure and Chemical Properties of General Anesthetic Agents 
   * DIETHYL ETHER   NITROUS OXIDE   HALOTHANE  ISOFLURANE * 
 
 
 
 
 XIII.  Sedative/Hypnotic Agents 
  A.  Benzodiazepines 
   1.  Structure, Chemical Properties, and SAR 
   2.  Biochemical effects 
    * DIAZEPAM  CHLORDIAZEPOXIDE  FLURAZEPAM  OXAZEPAM * 
    * TRIAZOLAM  MIDAZOLAM  LORAZEPAM   ZOLPIDEM * 
  B.  Barbiturates 
   1.  Chemical properties and SAR of agents 
   2.  Biochemical effects 
    * PHENOBARBITAL   PENTOBARBITAL   SECOBARBITAL * 
    * BUTABARBITAL THIOPENTAL * 
  C.  Non-barbiturates * CHLORAL HYDRATE  * 
 
 
 XIV.  Opioid Analgesic Agents 
  A.  Biochemistry of Endorphins, Enkephalins, and Their Receptors 
  B.  Natural Product and Model Agent     * MORPHINE * 
  C.  SAR, Stereochemistry, and Chemical Properties 
    1.  Chemical features of morphine 
   2.  N-Substituents producing agonist, partial agonist, or antagonist effects 
        3.  Synthetic agents 
   * HEROIN   HYDROMORPHONE   CODEINE   MEPERIDINE  LEVORPHANOL * 
   * BUTORPHANOL   METHADONE   FENTANYL   PENTAZOCINE   ETORPHINE * 
   * NALOXONE   NALTREXONE   DEXTROMETHORPHAN * 
 
 
 XV.  Antineoplastic Agents 
 A.  Chemistry and Mechanisms of Action for Alkylating and Cross-linking Agents 
* MECHLORETHAMINE  CHLORAMBUCIL  CYCLOPHOSPHAMIDE  IFOSFAMIDE * 
   * BUSULFAN  CARMUSTINE   LOMUSTINE  DACARBAZINE  PROCARBAZINE * 
  * CISPLATIN   CARBOPLATIN * 
  B.  Mechanisms of Action for Antimetabolite Agents 
  * METHOTREXATE  LEUCOVORIN  FLUOROURACIL  FLOXURIDINE * 
  * CYTARABINE  GEMCITABINE  CLADRIBINE PENTOSTATIN  MERCAPTOPURINE * 
  C.  Mechanisms of Action for Natural Products and Miscellaneous Agents 
  * VINCRISTINE   VINBLASTINE  PACLITAXEL  ETOPOSIDE * 
  *  ASPARAGINASE   HYDROXYUREA * 
  D.  Mechanisms of Action for Antibiotic Type Agents 
  * DAUNORUBICIN  DOXORUBICIN  IDARUBICIN  BLEOMYCIN * 
  * MITOXANTRONE  MITOMYCIN  DACTINOMYCIN * 
 
